Want to join the conversation?
In FY17, $CAH expects a high single digit percentage increase in Pharmaceutical revenue versus the prior year. Profit is expected to be essentially flat. In the Medical segment, $CAH expects revenue to increase in the mid single digit percentage range versus the prior year. The company expects double digit profit growth and margin rate expansion.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?